Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


With Shire Behind Him, Jonas Starts New Chapter At SAGE

This article was originally published in The Pink Sheet Daily

Executive Summary

The upbeat ex-Shire exec has moved on from his tumultuous break-up with the specialty pharma and is on day three in his new role as CEO of CNS start-up SAGE Therapeutics. He will focus on bringing CNS products forward for orphan indications.


Related Content

Financings of the Fortnight Wants To Spin You Right 'Round, And Out
Shire Sheds Dermagraft; Exits Regenerative Medicine
Eyeing Epilepsy Franchise, SAGE Therapeutics Raises $20M
People In The News: Government Officials Go Private; New Top Leadership At Advaxis, Aerie
Newly Appointed Head of Regenerative Medicine At Shire Plans Rapid Growth For The Division
Third Rock Wise To The Opportunity In CNS; Stakes SAGE Therapeutics With $35 Million
Advanced BioHealing To Bring Regeneration To Shire


Related Companies

Related Deals




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts